|
⚲
|
| Keyboard |
| Ron Laufer | |
|---|---|
| Firm | |
| Address | 79 Tw Alexander Drive 4401 Research Commons, Suite 105 Research Triangle Park, NC 27709 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| G1 Therapeutics Inc | 021-262918 | Director | 50.0 M of 50.0 M |
||
| Adheron Therapeutics Inc | 021-244897 | Director | 1.5 M of 1.5 M |
||
| Catabasis Pharmaceuticals Inc | 021-236973 | Director | 12.4 M of 20.4 M |
||
| G1 Therapeutics Inc | 021-233991 | Director | 16.5 M of 33.0 M |
||
| Ventirx Pharmaceuticals Inc | 021-225512 | Director | 15.0 M of 15.0 M |
||
| Catabasis Pharmaceuticals Inc | 021-206457 | Director | 32.4 M of 32.4 M |
||
| G1 Therapeutics Inc | 021-204775 | Director | 12.6 M of 12.6 M |
||
| Catabasis Pharmaceuticals Inc | 021-191213 | Director | 9.2 M of 9.2 M |
||
| Synovex Corp | 021-185289 | Director | 3.5 M of 7.0 M |
||
| Ventirx Pharmaceuticals Inc | 021-91597 | Director | 50.6 M of 53.1 M |
||